Subayno, April Kate .

HRN: 25-46-45  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2025
CEFUROXIME 750MG (VIAL)
08/29/2025
09/05/2025
IV
750mg
Q8
UTI
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary TractProphylaxis    Compliance to guidelines: Compliant To Guidelines